Last Updated: September 24, 2026

VINCRISTINE SULFATE PFS Drug Patent Profile

Name: VINCRISTINE SULFATE PFS Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Vincristine Sulfate Pfs patents expire, and what generic alternatives are available?

Vincristine Sulfate Pfs is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs.

The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for VINCRISTINE SULFATE PFS?
What are the global sales for VINCRISTINE SULFATE PFS?
What is Average Wholesale Price for VINCRISTINE SULFATE PFS?

Summary for VINCRISTINE SULFATE PFS

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	45
Clinical Trials:	482
Patent Applications:	3,055
DailyMed Link:	VINCRISTINE SULFATE PFS at DailyMed

Drug patent expirations by year for VINCRISTINE SULFATE PFS

Recent Clinical Trials for VINCRISTINE SULFATE PFS

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Children's Oncology Group	PHASE2
City of Hope Medical Center	PHASE2
National Cancer Institute (NCI)	PHASE2

See all VINCRISTINE SULFATE PFS clinical trials

Pharmacology for VINCRISTINE SULFATE PFS

Drug Class	Vinca Alkaloid

US Patents and Regulatory Information for VINCRISTINE SULFATE PFS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	VINCRISTINE SULFATE PFS	vincristine sulfate	INJECTABLE;INJECTION	071484-001	Apr 19, 1988		RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Pharms Usa	VINCRISTINE SULFATE PFS	vincristine sulfate	INJECTABLE;INJECTION	075493-001	Sep 1, 1999		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.